Introduction {#S0001}
============

Lung cancer is the most frequent malignant neoplasm, causing approximately 1.3 million deaths each year worldwide. It is also associated with one of the poorest prognoses among all types of cancer, with 5-year survival rates of about 12% for men and 17% for women.

Malignant neoplasms are the second leading cause of death in Poland, being responsible for 26% of deaths among men and 23% among women. In 2011, 144 thousand new cases of malignant neoplasms were reported in Poland, approximately 20 thousand of which were newly identified cases of lung cancer.

Due to the high percentage of tobacco smokers (about 41% of men and 19% of women), high levels of environmental pollution arising from heavy industrialization, as well as the demographic and economic situation of the region, in terms of morbidity (based on the standardized morbidity rate), the Łódź voivodeship occupied the 4^th^ position for the female population (approximately 550 new cases) and the 7^th^ position for the male population (with approximately 1000 new cases) in 2011 (on a national scale). In terms of mortality, based on the standardized mortality rate, the positions were the following: 8^th^ for the female population (approximately 460 deaths) and 9^th^ for the male population (approximately 1100 deaths). Since 2007, a trend has been visible in Poland each year where the number of lung cancer deaths among women has exceeded the number of deaths due to breast cancer (in spite of the opposite trend in the morbidity structure).

According to the current state of scientific knowledge, long-term exposure to inhaled carcinogens, especially tobacco smoke, is associated with the highest risk of lung cancer. It seems that, in the rare cases of lung cancer among non-smokers, a combination of genetic factors, passive smoking, and environmental pollution may constitute the cause.

Inhaling quartz, metal powders, mineral asbestos fibers, ozone, gasoline and diesel engine fumes, and particulate matter (PM~10,~ PM~2,5~) is especially significant in this process.

All these factors result in higher levels of reactive oxygen and nitrogen species (ROS and RNS) and increased oxidative stress in the respiratory system. This may lead to the overproduction of pulmonary inflammation mediators and the initiation or promotion of carcinogenesis. The initiation and promotion of pulmonary cancer has been linked to a series of biochemical pathways of oxidative stress. All aerobic organisms have evolved antioxidant defenses to protect themselves against ROS and RNS generated in vivo. The most important antioxidant enzymes are superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX).

The aim of this study is to evaluate the activity of selected antioxidative enzymes in patients with lung cancer before and after radical surgery.

A better understanding of the exact role and alteration of antioxidant profiles in lung cancer may contribute to the future use of antioxidants in the management of lung cancer.

Material and methods {#S0002}
====================

In the years 2012-2013, we enrolled and operated on 20 patients with non-small cell lung cancer (NSCLC) in clinical stages I (9 patients) and II (11 patients). The lesion was right-sided in 9 cases and left-sided in 11. The study group included 11 men and 9 women. Their ages ranged from 53 to 74 (mean: 61.9) ([Table I](#T0001){ref-type="table"}). The control group consisted of healthy volunteers: 9 men and 1 woman. Their ages ranged from 24 to 79 (mean: 42.9) ([Table II](#T0002){ref-type="table"}). All patients in the study group were ex-smokers suffering from NSCLC, qualified for lobectomy due to the stage of their disease. All patients were qualified for the surgical procedures after providing formal consent. They were operated on under general anesthesia with one-lung ventilation. Blood samples were taken twice in the study group (one day before the operation and one day after the operation) and once in the control group.

###### 

Characteristics of the study group

  Variable   *N*    Mean     Median   Min     Max      Q25      Q75      SD
  ---------- ------ -------- -------- ------- -------- -------- -------- -------
  Age        20     61.90    62.50    53.00   74.00    57.50    65.00    5.63
  Height     20     166.75   165.00   152.0   190.00   159.50   172.50   9.39
  Weight     20     68.150   68.00    45.00   91.00    59.50    78.00    13.33
  BMI        20     24.25    25.25    17.36   32.00    20.83    26.55    3.94
             Male   Female                                               
  Gender     *n*    \%       *n*      \%                                 
  11         55     9        45                                          

BMI -- body mass index

###### 

Characteristics of the control group

  Variable   *N*    Mean     Median   Min      Max      Q25      Q75      SD      
  ---------- ------ -------- -------- -------- -------- -------- -------- ------- --
  Age        10     42.90    43.00    24.00    79.00    28.00    46.00    17.00   
  Height     10     170.80   170.00   167.00   179.00   168.00   172.00   3.43    
  Weight     10     72.70    74.50    55.00    98.00    57.00    81.00    13.61   
  BMI        10     24.98    25.34    19.30    35.14    20.20    27.40    4.88    
             Male   Female                                                        
  Gender     *n*    \%       *n*      \%                                          
  9          90     1        10                                                   

BMI -- body mass index

Blood sample preparation {#S20003}
------------------------

Venous blood (5 ml) in lithium heparin was taken from each lung cancer patient (twice) and from each member of the control group (once). Red blood cells were separated from plasma and buffy coat by immediate centrifugation at 3500 r/min for 10 min and stored at --70°C for the subsequent assays of antioxidants activity. Red blood cell lysate was prepared by washing packed red blood cells three times with cold normal saline under centrifugation at 3500 r/min.

Hemoglobin assay {#S20004}
----------------

For the purpose of determining enzyme activity, hemoglobin (Hb) concentration in erythrocyte hemolysate was estimated at 540 nm using a spectrometer (UV/VIS Spectrometer Lambda 14P, Perkin Elmer, USA) after conversion into cyanmethemoglobin with Drabkin\'s reagent (Aqua-Med, Poland) \[[@CIT0001]\].

Catalase activity {#S20005}
-----------------

Catalase activity in erythrocytes was determined according to the spectrophotometric procedure described by Beers and Sizer (1952) \[[@CIT0002]\] and calculated in Bergmeyer units (BU/g Hb). Catalase activity was measured at 240 nm with a spectrometer at 25°C by recording H~2~O~2~ decomposition (UV/VIS Spectrometer Lambda 14P, Perkin Elmer, USA). One Bergmeyer unit (BU) of this activity is defined as the amount of enzyme decomposing 1 g of H~2~O~2~ per min.

Glutathione peroxidase activity {#S20006}
-------------------------------

Glutathione peroxidase activity in erythrocytes was measured according to the spectrophotometric procedure described by Little and O\'Brien (1952) \[[@CIT0003]\] and presented as enzymatic units (U/g Hb). The difference in the rate of GPX reaction with glutathione and cumene in the acquired samples is used for determining its activity by measuring absorbance with a spectrometer (UV/VIS Spectrometer Lambda 14P, Perkin Elmer, USA) at 412 nm. One unit of GPX activity is calculated as the amount of enzyme which causes a 10% decrease in the level of reduced glutathione within 1 min at 25°C, pH 7.0.

Superoxide dismutase activity {#S20007}
-----------------------------

Superoxide dismutase activity in erythrocytes was measured according to the procedure described by Misra and Fridovich (1972) \[[@CIT0004]\] and expressed in adrenaline units (U/g Hb/100 ml). SOD activity was determined by absorbance increase at 480 nm with a spectrometer at 37°C (UV/VIS Spectrometer Lambda 14P, Perkin Elmer, USA) followed by the auto-oxidation of adrenaline inhibited by CuZn-SOD. One unit of SOD activity is defined as the amount of enzyme inhibiting adrenaline auto-oxidation at 50%.

Total antioxidant status determination {#S20008}
--------------------------------------

Total antioxidant status in blood plasma was determined using the spectrophotometric method applied according to procedure no. NX2332 by Randox (Randox Laboratories Ltd. Ardmore, Diamond Road, Crumlin, Co Antrim, United Kingdom, BT29 4QY). In short, ABTS (2,2-azino-di\[3-ethylbenzthiazoline sulfonate\]) was incubated with peroxide (metmyoglobin) and H~2~O~2~ to produce a ABTS radical cation with relatively stable blue-green color. Antioxidants, when added to the examined sample, suppressed the production of this color, which was measured as absorbance decrease using a spectrometer (UV/VIS Spectrometer Lambda 14P, Perkin Elmer, USA) at 600 nm. The total antioxidant status was calculated as the concentration of antioxidants (mmol/l).

Statistical analysis {#S20009}
--------------------

Basic demographic data are expressed as mean, SD, median, and interquartile range.

Statistical analysis was performed using the Statistica ver. 6.0 software. The statistical analysis included the following: Student\'s *t*-test, Wilcoxon test, χ^2^, and Spearman\'s rank correlation coefficient. A *p*-value \< 0.05 was considered to be of statistical significance.

Results {#S0010}
=======

The activity of SOD, CAT, GPX, and TAS was determined in both the control group and the study group. Graphical analysis of the selected parameters in both groups before surgery is shown in [Figures 1](#F0001){ref-type="fig"}--[4](#F0004){ref-type="fig"}. The characteristics of the activity of individual antioxidative enzymes in the control group are presented in [Table III](#T0003){ref-type="table"}, while the data for the study group are presented in [Table IV](#T0004){ref-type="table"}. Lower activity of antioxidative enzymes was found in the study group prior to surgery in comparison to the control group, but only the differences in the CAT activity (11.45 \[5.20-29.17\] in the study group vs. 19.8 \[15.60-24.00\] in controls) and TAS (1.29 \[0.92-1.86\] in the study group vs. 1.67 \[1.19-1.80\] in controls) were statistically significant ([Table V](#T0005){ref-type="table"}). Statistically lower initial CAT activity and TAS were demonstrated in lung cancer patients in comparison to the group of healthy subjects. The difference in enzymatic activity after the operation between the study group and the control group was statistically insignificant ([Table VI](#T0006){ref-type="table"}). A statistically significant increase in GPX (52.13 \[27.51-97.75\] vs. 58.16 \[29.32-78\]) and CAT activity (11.45 \[5.20-29.17\] vs. 14.86 \[6.40-38.47\]) as well as TAS (1.29 \[0.92-1.86\] vs. 1.53 \[0.92-2.6\]) was noted in the study group after the operation. A statistically significant increase of SOD activity was not observed (1435.27 vs. 1483.98) ([Table VII](#T0007){ref-type="table"}). The changes in the above-listed parameters are presented in([Figures 5](#F0005){ref-type="fig"}--[8](#F0008){ref-type="fig"}). With the use of Spearman\'s rank correlation coefficient, the study group was tested for the relationship between enzyme activity (measured before and after surgery) and age, height, and BMI index, but no statistically significant correlation between these parameters was found.
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###### 

Quantitative characteristics of the enzymatic activity in the control group

  Variable   *N*   Mean       Median     Min       Max       Q25       Q75       SD
  ---------- ----- ---------- ---------- --------- --------- --------- --------- --------
  SOD        10    1782.300   1704.500   540.000   2430.00   1550.00   2269.00   550.78
  GPX        10    52.60000   55.00000   34.0000   66.9000   45.0000   56.7000   9.240
  CAT        10    19.80000   19.80000   15.600    24.00     19.800    19.80     1.98
  TAS        10    1.679000   1.800000   1.1900    1.8000    1.8000    1.800     0.26

SOD -- superoxide dismutase, GPX -- glutathione peroxidase, CAT -- catalase, TAS -- total antioxidant status

###### 

Quantitative characteristics of the enzymatic activity in the study group

  Variable               *N*   Mean       Median     Min      Max       Q25       Q75       SD
  ---------------------- ----- ---------- ---------- -------- --------- --------- --------- --------
  SOD before operation   20    1435.275   1392.500   243.00   3400.0    835.50    1802.0    832.26
  SOD after operation    20    1483.985   1317.00    158.00   3566.70   1023.00   2099.00   868.65
  GPX before operation   20    52.13500   51.45000   27.51    97.75     40.95     61.45     16.48
  GPX after operation    20    58.16050   57.95000   29.320   78.00     55.00     67.90     12.98
  CAT before operation   20    11.45550   9.750000   5.20     29.17     7.40      13.95     5.84
  CAT after operation    20    14.86850   12.95000   6.40     38.47     8.60      17.80     7.97
  TAS before operation   20    1.296500   1.290000   0.9200   1.8600    1.1450    1.3450    0.2245
  TAS after operation    20    1.536500   1.540000   0.92     2.600     1.315     1.725     0.38

SOD -- superoxide dismutase, GPX -- glutathione peroxidase, CAT -- catalase, TAS -- total antioxidant status

###### 

Statistical significance of the differences in preoperative enzymatic activity between the study group and the control group

  Variable                               *p*
  -------------------------------------- ----------
  Preoperative SOD & postoperative SOD   0.244280
  Preoperative GPX & postoperative GPX   0.934831
  Preoperative CAT & postoperative CAT   0.000158
  Preoperative TAS & postoperative TAS   0.000241

###### 

Statistical significance of the differences in postoperative enzymatic activity between the study group and the control group

  Variable                               *p*
  -------------------------------------- ----------
  Preoperative SOD & postoperative SOD   0.406495
  Preoperative GPX & postoperative GPX   0.379098
  Preoperative CAT & postoperative CAT   0.151752
  Preoperative TAS & postoperative TAS   0.435339

###### 

Statistical significance of the differences between the preoperative and postoperative enzymatic activity in the study group

  Variable                               *p*
  -------------------------------------- ----------
  Preoperative SOD & postoperative SOD   0.822761
  Preoperative GPX & postoperative GPX   0.040136
  Preoperative CAT & postoperative CAT   0.025094
  Preoperative TAS & postoperative TAS   0.030366

Discussion {#S0011}
==========

Each day, our lungs are exposed to various oxidants of either endogenous or exogenous origin, especially air pollutants and cigarette smoke. Cigarette smoke is a complex aerosol that consists of thousands of chemical compounds, some of which have been identified as carcinogens. Numerous studies have shown that smoking cigarettes is associated with inflammation and oxidative stress. Tobacco smoke, which contains 10^14^ ROS and 700 ppm NO per puff \[[@CIT0005]\], is the main cause of lung cancer; in the USA it is responsible for almost 87% of cases \[[@CIT0005]\]. In developing countries, it remains the leading cause of cancer mortality, which is also the case in Poland \[[@CIT0006]\]. The risk increases with the time of smoking and the daily amount of tobacco used. Cigarette smoke leads to chronic airway inflammation with the accumulation and activation of leukocytes, neutrophils, and macrophages, which play a pivotal role in the regional and systemic effects of oxidative stress \[[@CIT0005], [@CIT0007], [@CIT0008]\]. After activation, leukocytes and neutrophils produce high levels of reactive oxygen (ROS) and nitrogen species (RNS). Resident macrophages in the airways can release ROS/RNS after the phagocytosis of the inhaled particles, as well as releasing TNF-α-cytokine, which contributes to the spread of inflammatory processes in the airway epithelium \[[@CIT0008]\]. Reactive oxygen or nitrogen species (ROS, RNS) in the respiratory system increase the production of pulmonary inflammation mediators and initiate or promote the mechanisms of carcinogenesis. Increased oxidant production has been revealed in smokers and patients with lung cancer in many previous publications \[[@CIT0009], [@CIT0010]\].

Free radicals are reactive compounds that have one or more unpaired electrons in their valence shell. ROS are produced in cellular sites by electron transfer reactions through enzymatic and non-enzymatic processes. The main sources of ROS are mitochondria, cytochrome P450, and peroxisomes \[[@CIT0008], [@CIT0011]\]. Under physiological conditions there takes place constant production of ROS and RNS, which play an important role as secondary messengers in metabolic processes. At higher concentrations, free radicals and ROS/RNS are hazardous to living organisms. An excessive or sustained increase in ROS production can, if not balanced by antioxidant enzymes and non-enzymatic cellular antioxidant defenses, cause oxidative damage to all major cellular constituents (especially DNA). However, ROS can be either anticarcinogenic, by promoting apoptosis or inhibiting angiogenesis, or procarcinogenic, due to their ability to promote proliferation, angiogenesis and metastasis, and suppress apoptosis. ROS-induced DNA damage involves, for instance, single- or double-stranded DNA breaks, purine and/or pyrimidine modifications, as well as transcription and replication errors \[[@CIT0011], [@CIT0012]\].

All aerobic organisms have developed a series of defense mechanisms, including prevention mechanisms, repair mechanisms, physical defenses, and antioxidant defenses. These antioxidants can intercept, scavenge, and neutralize radicals and their reactive intermediates. The most significant antioxidant enzymes are superoxide dismutase (SOD), occurring in 3 isoforms, catalase (CAT), and glutathione peroxidase (GPX) \[[@CIT0012], [@CIT0013]\].

Non-enzymatic antioxidants include vitamin E, vitamins C and A, selenium, transferrin, and lactoferrin. Antioxidants are mainly situated intracellularly \[[@CIT0013]\]. The term "oxidative stress" is defined as the adverse condition resulting from an imbalance between cellular oxidants (mostly ROS and RNS) and antioxidants (enzymatic, such as CAT and SOD, and others).

The present study demonstrates that the preoperative enzymatic activity in the study group was lower in comparison to the control group, but statistical significance was only found in the case of CAT activity and TAS. After the operation, we found statistically significant differences in the study group with respect to the activity of GPX and CAT as well as TAS; the activity of the enzymes increased. The activity of SOD increased as well, but this increase was not statistically significant. In comparison to the control group, the activity of antioxidative enzymes in patients with lung cancer was lower (both preoperative and postoperative levels), with the exception of the activity of GPX, whose level was decreased before and increased after the operation in the study group; these numbers, however, were not statistically significant. The alteration in systemic antioxidant profile was independent of age, height, and BMI parameters.

Our study showed that the enzymatic activity of antioxidative enzymes is lower in patients with lung cancer, which was also confirmed by other authors \[[@CIT0012]\]. Similarly to other publications, we established that the surgical removal of lung cancer resulted in the augmentation of the total plasma antioxidant parameters; however, the activity was lower than in the control group, except for GPX \[[@CIT0013]\].

Our results confirmed that the activity of antioxidative enzymes is lower in patients with lung cancer, but further research is necessary to establish and investigate the significance of the systemic antioxidant activities as markers of disease status, especially in its early stages.

Conclusions {#S0012}
===========

Oxidative mechanisms, when their function is impaired, may lead to chronic inflammation, which may in turn contribute to carcinogenesis. The results of this study show that patients with lung cancer exhibit lower activity of major antioxidative enzymes in comparison to controls; radical resection of the tumor contributes to increasing the activity of those enzymes, but it remains lower in comparison to the healthy population.
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